Pharmaceutical Contract Packaging Market Value is Projected to Reach US$ 27.1 Billion by 2024

1. GlobalPharmaceutical Contract Packaging Market Report, Historical Growth & Analysis of Top Key Players Copyright © IMARC Service Pvt Ltd. All Rights Reserved

2. About IMARC Group Report Description IMARC is a leading advisor on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description Pharmaceutical Contract Packaging Market Report By Type (Sterile and Non-Sterile), Packaging (Plastic Bottles, Caps and Closures, Blister Packs, Prefilled Syringes and Parenteral Vials & Ampules), Industry, Region Over the past few years, the global pharmaceutical contract packaging market has witnessed a healthy growth. This can be accredited to factors like rigid government policies, increasing investment in R&D activities and rising popularity of smart labels. Market Overview: As per the latest report by IMARC Group, titled “Pharmaceutical Contract Packaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023”, the global pharmaceutical contract packaging market reached a value of more than US$ 10 Billion in 2017. In order to provide an optimum pharmacological effect to the patients, drugs require to be safely packed after production. To ensure this, pharmaceutical companies outsource secondary operations such as labeling and packaging of drugs to contract firms. Pharmaceutical contract packaging is more profitable, flexible and assists in keeping up with the changing times. Contract packaging firms also provide secondary services like assembling, secondary packaging, and labelling of vials, pre-filled syringes and auto-injectors.

4. Report Description and Highlights Report Description • Market Trends: • The implementation of strict rules and regulations by the governing agencies regarding the packaging of drugs has been the major growth-inducing factor for the market. Moreover, as opposed to drug manufacturers, pharmaceutical contract packaging vendors can undertake different types of packaging projects and can easily sort issues which arise from the complex packaging requirements. Further, these vendors are investing in research and development activities to improve the quality of their offerings. Apart from this, as these companies have a global presence, it helps the pharmaceutical companies in creating a fluid channel for the distribution of medicines and medical equipment across various regions. Additionally, the growing employment of smart packaging solutions, such as smart labels, is expected to create a positive outlook for the market. Looking forward, the market value is projected to reach US$ 16 Billion by 2023, expanding at a CAGR of 7% during 2018-2023. • Request for a sample report: https://www.imarcgroup.com/request?type=report&id=524&flag=B • Pharmaceutical Contract Packaging Market Segmentation: • Market Segmentation by Product Industry • Small Molecule

5. Market Forecast Sample Figure: Global: Pharmaceutical Contract Packaging Market Forecast: Sales Value Trends (in Billion US$), 2018 - 2023

6. Market Segmentation Report Description • Biopharmaceutical • Vaccine • On the basis of industries, the market has been segregated into small molecule, biopharmaceutical and vaccine. At present, small molecule represents the leading industry, accounting for the majority of the total market share. • Market Segmentation by Type • Sterile • Non-Sterile • Based on types, the market has been bifurcated into sterile and non-sterile segments. Currently, the sterile segment dominates the market, holding the largest share. • Market Segmentation by Packaging • Plastic Bottles • Caps and Closures • Blister Packs

7. Market Segmentation Report Description • Prefilled Syringes • Parenteral Vials and Ampules • On the basis of packaging, plastic bottles account for the biggest market share, followed by caps and closures, blister packs, prefilled syringes, and parenteral vials and ampules. • For more information, click here: https://www.imarcgroup.com/pharmaceutical-contract-packaging-plant • Market Segmentation by Region • United States • Europe • China • India • Latin America • Others • Region-wise, the market has been segmented into the United States, Europe, China, India and Latin America. Amongst these, the United States is the leading market, holding the dominant share.

8. Market Segmentation Report Description Competitive Landscape: The competitive landscape of the market has also been examined in the report with the detailed profiles of the key players operating in the market. In case you have a very specific customized or specific niche needs, we can work around the scope of work and assist you with the tailor made solution. The topics covered could be technology, markets, competition, pricing trends, P&L analysis, cost analysis, price bench marking or it could also be supplementing you with the weekly or fortnight reports.

9. Team Profile Our Team Comes From Some of the Top Universities Globally. Team Profile 60% Engineering and Science 5% Others 35% Business Studies Average Experience of 7+ Years Over 2000 Independent Consultants from different sectors.

10. Partial List of Clients • We are the trusted business partners to the world's leading corporates, governments, and institutions A partial List of our Clients

11. Partial List of Clients • We are the trusted business partners to the world's leading corporates, governments, and institutions A partial List of our Clients

12. Report Description and Highlights Report Description © 2018 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

13. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: • TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com